Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Adagio Therapeutics Inc (ADGI)

Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 504,976
  • Shares Outstanding, K 108,831
  • Annual Sales, $ 0 K
  • Annual Income, $ -226,790 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.23
Trade ADGI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.15
  • Most Recent Earnings $-0.47 on 08/15/22
  • Next Earnings Date 09/19/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.46
  • Number of Estimates 3
  • High Estimate -0.39
  • Low Estimate -0.52
  • Prior Year -0.98
  • Growth Rate Est. (year over year) +53.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.75 +23.73%
on 08/16/22
4.90 -5.31%
on 08/22/22
+0.65 (+16.29%)
since 08/12/22
3-Month
2.41 +92.53%
on 06/15/22
4.90 -5.31%
on 08/22/22
+1.68 (+56.76%)
since 06/10/22
52-Week
2.41 +92.53%
on 06/15/22
78.82 -94.11%
on 11/30/21
-49.26 (-91.39%)
since 09/10/21

Most Recent Stories

More News
INVIVYD 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 3, 2023 to file lead plaintiff applications...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)
INVIVYD SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. - IVVD, ADGI

/PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 3, 2023 to file lead plaintiff applications...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Invivyd, Inc. - IVVD, ADGI

/PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Invivyd, Inc. (the "Company") (NasdaqGM: IVVD)...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)
INVIVYD SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. - IVVD, ADGI

/PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)
INVIVYD SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. - IVVD, ADGI

/PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 3, 2023 to file lead plaintiff applications...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Invivyd, Inc. - IVVD, ADGI

/PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Invivyd, Inc. (the "Company") (NasdaqGM: IVVD)...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)
INVIVYD SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. - IVVD, ADGI

/PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)
INVIVYD SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. - IVVD, ADGI

/PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 3, 2023 to file lead plaintiff applications...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Invivyd, Inc. - IVVD, ADGI

/PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Invivyd, Inc. (the "Company") (NasdaqGM: IVVD)...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)
INVIVYD SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. - IVVD, ADGI

/PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have...

IVVD : 1.1900 (+1.71%)
ADGI : 4.64 (+0.87%)

Business Summary

Adagio Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. Adagio Therapeutics Inc. is based in WALTHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 5.13
2nd Resistance Point 4.93
1st Resistance Point 4.79
Last Price 4.64
1st Support Level 4.45
2nd Support Level 4.25
3rd Support Level 4.11

See More

52-Week High 78.82
Fibonacci 61.8% 49.63
Fibonacci 50% 40.62
Fibonacci 38.2% 31.60
Last Price 4.64
52-Week Low 2.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar